
Ethyl cyclohexanecarboxylate | CAS:3289-28-9
Ethyl cyclohexanecarboxylate
- Name:Ethyl cyclohexanecarboxylate
- CAS:3289-28-9
- Synonyms:Cyclohexanecarboxylic acid ethyl ester
- Molecular Formula:C9H16O2
- Molecular Weight:156.22
- EINESC:221-945-7
Description
Properties
没有数据 | 没有数据 |
---|
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
Alfa-Aesar | View & Download |
Combi-Blocks | View & Download |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Species differences and substrate specificity of CYP3A heteroactivation by efavirenz.Yohei Kosugi et al.Xenobiotica; the fate of foreign compounds in biological systems, 45(4), 345-352 (2014-11-12)
Enhancement of CYP3A4 activity in Hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha.Tsai-Shin Chiang et al.PloS one, 9(4), e94885-e94885 (2014-04-16)
Interactions of endosulfan and methoxychlor involving CYP3A4 and CYP2B6 in human HepaRG cells.Camille C Savary et al.Drug metabolism and disposition: the biological fate of chemicals, 42(8), 1235-1240 (2014-05-17)
Occurrence and measurement of nifedipine and its nitropyridine derivatives in human blood plasma.J Dokladalova et al.Journal of chromatography, 231(2), 451-458 (1982-09-10)
The first pass metabolism of nifedipine in man.D G Waller et al.British journal of clinical pharmacology, 18(6), 951-954 (1984-12-01)
Structure-function analysis of porcine cytochrome P450 3A29 in the hydroxylation of T-2 toxin as revealed by docking and mutagenesis studies.Guyue Cheng et al.PloS one, 9(9), e106769-e106769 (2014-09-04)
Isotopic sensitivity in the microsomal oxidation of the dihydropyridine calcium entry blocker nifedipine.J L Born et al.Chemical research in toxicology, 2(1), 57-59 (1989-01-01)
Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this.Ju-Xiu He et al.The Journal of pharmacy and pharmacology, 66(11), 1623-1630 (2014-06-26)
Delamanid does not inhibit or induce cytochrome p450 enzymes in vitro.Yoshihiko Shimokawa et al.Biological & pharmaceutical bulletin, 37(11), 1727-1735 (2014-11-05)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!